In summary, the risk factors associated with cfDNA‐positive adenomas included a mixture of CRA with adenocarcinoma, a large CRA size (exceeding 2 × 2 cm), and the copresence of APC and KARS mutations. This evidence concerns the gene KARS1 and adenocarcinoma.